The Sphere-9 catheter (Medtronic) Medtronic said its ... heart tissue has been scarred from a previous heart attack. “Currently approved treatments for VT involve only RF energy and require ...

Medtronic has announced US Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Affera Mapping and Ablation System for sustained VT, a serious heart condition.

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

Medtronic announced new long-term data from the SPYRAL HTN-ON MED clinical trial of the company’s Symplicity Spyral renal ...

Medtronic has announced new clinical ... system in atrial fibrillation (Afib) treatment. The study, presented at the Asia Pacific Heart Rhythm Society meeting, indicated that 98% of pulmonary ...

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

Pacemakers send electrical pulses to regulate a person’s heart rate and ... vice president of Medtronic’s cardiac pacing therapies. The blackout was front page news even before the child ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation ...

their families and societies of improving access to timely stroke diagnosis and treatment. Philips and Medtronic Neurovascular also further expanded and strengthened their partnerships with the World ...

their families and societies of improving access to timely stroke diagnosis and treatment. Philips and Medtronic Neurovascular also further expanded and strengthened their partnerships with the ...